Icosagen AS
Public limited company
- 10565884
- EE100573055
- Tartu maakond, Kambja vald, Õssu küla, Eerika tee 1, 61713
Company Icosagen AS has been registered on 27/08/1999. The status of the company is Active.
The net sales for 2024 were 2 035 311 euros. The net sales of Icosagen AS increased compared to 2023. The profit margin for 2024 is 6%. It has increased compared to 2023
The company's activity is Research and experimental development on natural sciences and engineering.
Empower Your Business
See all our solutions to grow your business
General Information
Company name in the business register
Icosagen AS
Previous and other name(s)
aktsiaselts Quattromed
osaühing Quattromed
ICOSAGEN AS
Company type
Public limited company
Registration number
10565884
D-U-N-S number
367130502
Registered
Aug 27, 1999 over 26 years ago
Registered capital
192,448 EUR
VAT number
EE100573055 from Dec 1, 1999 over 26 years
Status
Active
Contact data
Physical address
Tartu maakond, Kambja vald, Õssu küla, Eerika tee 1, 61713
Fax
E-mail address
Telephone
Internet address (www)
Quarterly taxes paid
Source: Estonian Tax and Customs Board
Responsible persons
| Name | Personal ID / Date of birth | Role | From |
|---|---|---|---|
| Mart Ustav | 34907×××××× | Management board member | Nov 24, 2008 |
| Mart Ustav | 38607×××××× | Management board member | Jan 20, 2023 |
Source: Estonian Business Registry (RIK)
Representation rights
- Every member of the Management Board may represent the public limited company in concluding all transactions.
Source: Estonian Business Registry (RIK)
Shareholders, supervisory board and other persons
D&B Risk Analytics Compliance Intelligence
D&B Risk Analytics Compliance Intelligence provides compliance teams with industry-leading data and modern capabilities to manage third-party compliance risk. Through intelligent and highly configurable policy-based workflows, D&B Risk Analytics Compliance Intelligence provides a state-of-the-art automated KYC/KYB monitoring solution that helps companies stay informed of risks in near real-time.
Product is designed to help compliance teams quickly and efficiently review, assess, monitor, and manage entities and related parties, including beneficial owners and significant control persons.
More information
can be found in
Financial information
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 2 035 311 | ↑5% | 1 938 317 | ↓-19.75% | 2 415 477 | ↓-32.65% | 3 586 426 |
| Net profit (loss) | 119 181 | ↑104.25% | 58 350 | ↓-74.28% | 226 859 | ↓-82.80% | 1 318 758 |
| No of employees | - | - | - | - |
What are the company's liabilities, current assets, equity and balance volume?
Dun & Bradstreet Finance Analytics gives you access to additional economic indicators - short-term liabilities, current assets, equity and balance volume. Everything you need for credit risk management across companies of all sizes worldwide.
More information
can be found in